Search Results - F. Gay

  • Showing 1 - 14 results of 14
Refine Results
  1. 1

    DEBATE UPFRONT vs DELAYED TRANSPLANT by F. Gay

    Published in HemaSphere (2023-05-01)
    Get full text
    Article


  2. 2

    Saber y conducta : los límites de la actuación individual en "La Ilíada" by Luis F. Gay Molins, Gabriel Sopeña Genzor

    Get full text
    Article


  3. 3

    El impacto del contexto socioeconómico para lograr la certificación Leed Platinum en edificios de países desarrollados y en desarrollo by Sandeep Langar, Annie R. Pearce, Leon F. Gay Alanís

    Published in Entretextos (2016-12-01)
    Get full text
    Article


  4. 4

    Exploring possible magnetic monopoles-induced magneto-electricity in spin ices by Y. Alexanian, J. Saugnier, C. Decorse, J. Robert, R. Ballou, E. Lhotel, J. Debray, F. Gay, V. Simonet, S. de Brion

    Published in npj Quantum Materials (2024-09-01)
    Get full text
    Article


  5. 5

    P183 | DELAYED DARATUMUMAB ADDITION TO LENALIDOMIDE-DEXAMETHASONE IN OLDER MULTIPLE MYELOMA PATIENTS: INSIGHTS FROM REAL-WORLD DATA by L. Cani, A. Di Nicola, A. Evangelista, I. Delle Donne, G. Bertuglia, A. Casson, M. D’agostino, F. Gay, A. Larocca, E. Marchetti, R. Mina, S. Oliva, T. Picardi, B. Bruno, S. Bringhen, G. Benevolo

    Published in Haematologica (2025-09-01)
    Get full text
    Article


  6. 6

    C003 | MODELING LONG-TERM PROGRESSION-FREE SURVIVAL IN TRANSPLANT-ELIGIBLE AND TRANSPLANT-INELIGIBLE NEWLY DIAGNOSED MULTIPLE MYELOMA TREATED WITH DARATUMUMAB, BORTEZOMIB, LENALIDO... by F. Gay, P. Sonneveld, S. Zweegman, T. Facon, V. Hungria, N. J. Bahlis, P. Moreau, H. Einsele, M. Boccadoro, F. Borgsten, A. Lam, M. Nobrega, V. Kovacs, J. Wang, M. Rowe, A. Sitthi-Amorn, R. Carson, M.A. Dimopoulos, P. Rodríguez-Otero, S.Z. Usmani

    Published in Haematologica (2025-09-01)
    Get full text
    Article


  7. 7

    P23 EMAGINE/CARTITUDE-6: A RANDOMIZED PHASE 3 STUDY OF DVRD FOLLOWED BY CILTACABTAGENE AUTOLEUCEL VERSUS DVRD FOLLOWED BY AUTOLOGOUS STEM CELL TRANSPLANT IN TRANSPLANT-ELIGIBLE PAT... by A. Broijl, J. San-Miguel, K. Suzuki, A. Krishnan, N. van de Donk, G. Cook, A. Jakubowiak, D. Madduri, S. Afifi, A. Stevens, J. Schecter, W. Deraedt, S. Kuppens, P. Mistry, L. Pacaud, M. Boccadoro, F. Gay, R. Mina, L. Rasche, P. Moreau, M. Mateos, H. Einsele, P. Sonneveld

    Published in HemaSphere (2023-05-01)
    Get full text
    Article


  8. 8

    B05 PLASMA CELL LEUKEMIA-LIKE STATUS HAS INDEPENDENT PROGNOSTIC VALUE IN THE CONTEXT OF THE SECOND REVISION OF THE INTERNATIONAL STAGING SYSTEM by D. Hofste op Bruinink, R. Kuiper, M. van Duin, T. Cupedo, V. van der Velden, R. Hoogenboezem, B. van der Holt, B. Beverloo, E. Valent, M. Vermeulen, M. D’Agostino, F. Gay, A. Broijl, H. Avet-Loiseau, N. Munshi, P. Musto, P. Moreau, S. Zweegman, N. van de Donk, P. Sonneveld

    Published in HemaSphere (2023-05-01)
    Get full text
    Article


  9. 9

    P13: CAN PATIENT-REPORTED OCULAR SYMPTOMS GUIDE DOSE MODIFICATIONS IN PATIENTS WITH RELAPSED/REFRACTORY MULTIPLE MYELOMA RECEIVING BELANTAMAB MAFODOTIN? by R Popat, A Badros, S Kumar, P Rodriguez-Otero, A Cohen, S Manier, P Voorhees, F Gay, R Rifkin, T Martin, A Chari, K Weisel, A Farooq, B Jeng, W Chng, H Lee, J Berdeja, V Jadhav, A Tosolini, L Eliason, A Palumbo, M Dimopoulos, S Lonial, S Trudel, P Richardson, E Terpos

    Published in HemaSphere (2022-04-01)
    Get full text
    Article


  10. 10

    B05: RESULTS FROM A META-ANALYSIS OF CILTACABTAGENE AUTOLEUCEL COMPARED TO PHYSICIAN’S CHOICE OF TREATMENT IN PATIENTS WITH RELAPSED OR REFRACTORY MULTIPLE MYELOMA by F Gay, JG Berdeja, V De Stefano, P Hari, B Hooper, A Haltner, S Kumar, T Martin, M-V Mateos, P Moreau, E Rosta, IA Samjoo, SZ Usmani, K Weisel, CC Jackson, Y Olyslager, JM Schecter, M Vogel, A Garrett, S Lee, T Nesheiwat, L Pacaud, C Zhou, S Valluri, LJ Costa, Y Lin

    Published in HemaSphere (2022-04-01)
    Get full text
    Article


  11. 11

    B02 CARFILZOMIB AND LENALIDOMIDE-BASED THERAPY FOR THE TREATMENT OF PRIMARY PLASMA CELL LEUKEMIA: RESULTS OF THE FINAL ANALYSIS OF THE PROSPECTIVE PHASE 2 EMN12/HOVON-129 STUDY FOR... by N. van de Donk, M.C. Minnema, B. van der Holt, F. Schjesvold, K.L. Wu, A. Capra, A. Broyl, W.W.H. Roeloffzen, A.P.A. Gadisseur, G. Pietrantuono, L. Pour, V. van der Velden, T. Lund, M. Offidani, M. Grasso, L. Giaccone, M. Cavo, T. Silkjaer, J. Caers, S. Zweegman, R. Hajek, R. Benjamin, A. Vangsted, M. Boccadoro, F. Gay, P. Sonneveld, P. Musto

    Published in HemaSphere (2023-05-01)
    Get full text
    Article


  12. 12

    B01 | ANALYSIS OF SUSTAINED MINIMAL RESIDUAL DISEASE NEGATIVITY IN PATIENTS WITH NEWLY DIAGNOSED MULTIPLE MYELOMA TREATED WITH CARFILZOMIB-LENALIDOMIDE-DEXAMETHASONE WITH OR WITHOU... by F. Gay, W. Roeloffzen, M.A. Dimopoulos, L. Rosiñol, M. Van Der Klift, A. Oriol, E. Katodritou, K. L. Wu, P. Rodríguez Otero, R. Hájek, I. Attucci, E. Zamagni, M. Van Duin, M. D'agostino, A. Belotti, S. Mangiacavalli, M. Grasso, G. Margiotta Casaluci, M. Offidani, G.M. De Sabbata, F. Fioritoni, P. Tosi, P. Musto, F. Schjesvold, J. Bladé, H. Einsele, P. Sonneveld, M. Boccadoro, A. Broijl

    Published in Haematologica (2025-09-01)
    Get full text
    Article


  13. 13

    C061 | CARFILZOMIB INDUCTION, CONSOLIDATION, AND MAINTENANCE WITH OR WITHOUT AUTOLOGOUS STEM-CELL TRANSPLANT: LONG-TERM FOLLOW-UP OF THE RANDOMISED, PHASE 2 FORTE TRIAL by F. Gay, G. Bertuglia, D. Rota-Scalabrini, A. Belotti, L. Paris, M. Cea, F. Patriarca, M. D'agostino, M. Gentile, M. Luppi, G. De Sabbata, S. Palmieri, G. Pietrantuono, A.M. Liberati, R. Bassan, F. Monaco, P. Tosi, O. Annibali, F. Pisani, P. Galieni, N. Pescosta, L. De Rosa, R. Zambello, M.T. Petrucci, P. Corradini, M. Offidani, B. Bruno, M. Boccadoro, E. Zamagni, P. Musto

    Published in Haematologica (2025-09-01)
    Get full text
    Article


  14. 14

    P20 LENALIDOMIDE MAINTENANCE AFTER VTD INDUCTION AND AUTOLOGOUS STEM CELL TRANSPLANTATION: PRELIMINARY RESULTS OF A REAL-LIFE STUDY INCLUDING 389 PATIENTS by G. Barilà, A. Pascarella, C. Conticello, R. Mina, C. Marcon, F. Fazio, C. Cartia, G. Buda, S. Pilerci, S. Rocchi, A. Maroccia, N. Sgherza, M. Porrazzo, N. Pescosta, A. Furlan, E. Scomazzon, G. Mele, M. Gentile, M.L. Del Giudice, G. Schininà, L. Pavan, G. De Cicco, A. Casson, C. Lisi, E. Antonioli, S. Mangiacavalli, P. Musto, F. Gay, E. Zamagni, M.T. Petrucci, F. Di Raimondo, F. Patriarca, R. Bassan, R. Zambello

    Published in HemaSphere (2023-05-01)
    Get full text
    Article


Search Tools: